The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
10/26/2022 | Tommy Duncan | 3 min read
Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?
10/24/2022 | 2 min read
Voting is now open for the 2023 Company of the Year Awards – make sure you have your say!
10/21/2022 | Stephanie Sutton | 10 min read
The remarkable story of gene therapy drug development during the 1990s and early 2000s.
10/07/2022 | Suparna Sanyal | 5 min read
Demand for gene therapies is rising, so all the more reason to better understand the properties of their delivery devices
09/17/2022 | Stephanie Sutton | 2 min read
ISCT speaks out after US court rules that stem cell therapy does not fall under FDA jurisdiction.
09/06/2022 | Angus Stewart | 9 min read
Diversity, support networks, and unexpected journeys: what nine years of C&G biz wisdom can teach us
08/29/2022 | Cedric Picaud | 3 min read
How can companies realistically incorporate patient-centric practices into cell and gene product development?
08/24/2022 | Angus Stewart | 4 min read
Can cell and gene therapy help bring an end to rare eye diseases?
08/11/2022 | Angus Stewart | 9 min read
ISCT’s new president talks platforms, regulation, and knowledge-transfer for the next generation
07/29/2022 | Angus Stewart | 9 min read
What happened at ISCT 2022’s return to in-person conferencing – and what can a new film release do for advanced therapy?
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse